BEL share buy analysis: ICICI Direct sees ₹530 on backlog

Why BEL is trending in market chatter

Bharat Electronics (BEL) is being discussed heavily across Reddit and social feeds after a broker note reiterated a BUY call and laid out near-term programme triggers. The conversation is also picking up because the stock recently traded close to its 52-week low zone, which some users see as a possible entry point. Over September 25, 2026 to October 1, 2026, BEL fell about 2.65% and closed at ₹383.10 on October 1. The same day, it touched a 52-week low of ₹378.65, with the 52-week high cited at ₹473.45. Alongside price action, people are reacting to mixed operating margin trends even as revenue and profit grew. Management commentary on order timing and large expected awards is another reason for attention. Some posts also highlight BEL’s role as a Navratna defence PSU and its leadership position in domestic defence electronics. The net result is a debate that blends valuation, execution visibility, and working-capital stress.

ICICI Direct BUY call and what it is based on

ICICI Direct Research maintained a BUY rating on BEL and discussed strong earnings visibility from a large and diversified order backlog. The brokerage’s thesis also leans on a robust pipeline in strategic defence programmes and improving execution backed by rising indigenisation. ICICI Direct values BEL at 45 times FY28E EPS to arrive at a target price of ₹530 per share. Social posts widely quoted the target versus prices cited around ₹368.9 (CMP in the broker snapshot) and ₹387.40 (as on 06-Oct-2026 16:00 IST). The same broker update (dated July 28, 2026) noted that lower Q1FY27 order inflows reflected timing, as FY26 inflows exceeded internal expectations. Management indicated FY26 inflows were higher than planned, which influenced quarterly comparables. Investors are also discussing the broker’s FY27E and FY28E estimates that were circulated with the note. While the recommendation is bullish, the community is also flagging operational risks that can affect execution even with a strong backlog.

Q4 FY26 results: growth held up, margins softened

BEL reported Q4 FY26 revenue of ₹10,224.4 crore, up 11.7% year-on-year and 42.9% quarter-on-quarter, described as in line with expectations and provisional numbers. EBITDA rose 5.9% year-on-year to ₹2,981.7 crore. EBITDA margin declined 162 basis points year-on-year to 29.2%, which became a key point in online discussions. Some users frame the quarter as operationally solid because revenue growth stayed strong while margins eased. Others focus on margin compression as a warning sign when the stock trades at a premium multiple. For FY26, revenue increased 16.2% to ₹27,610 crore, and PAT rose 13.9% to ₹6,062 crore. ICICI Direct attributed the FY26 margin improvement to healthy execution and increasing indigenisation. Separately, social summaries also referenced Q1 FY27 revenue growth of 25.3% year-on-year alongside an EBITDA margin contraction to about 25.83% due to escalating material costs.

FY27 guidance: growth above 15%, margin above 28%

Management guided for FY27E revenue growth of more than 15% and EBITDA margin above 28%. For many investors, that guidance matters because it sets expectations after margin discussion points in Q4 FY26 and Q1 FY27. The broker note also framed the execution pipeline as healthy, which supports the guidance if orders convert on schedule. In the July 28, 2026 update, the timing of order inflows was positioned as a factor behind quarter-to-quarter variability rather than a demand problem. Management also guided FY27 receivable days at 140-150 days, which is being debated as a working-capital pressure point. Some users compare this guidance with other references that cite high debtors around 170 days and rising working-capital days. The key takeaway from the discussion is that growth guidance is strong, but cash conversion metrics are closely watched. Investors are treating FY27 execution and collections as important alongside order wins.

Order inflows, backlog visibility, and the QRSAM timeline

BEL’s FY26 order inflows were cited at ₹30,045 crore, and the order backlog stood at ₹73,882 crore as of March 2026. The backlog is described as about 2.8 times FY26 revenue and providing visibility for roughly two to three years. Management guided for more than ₹55,000 crore of order inflows in FY27E, which includes an approximately ₹30,000 crore QRSAM order. QRSAM signing was expected by end of June, with a 5-10% chance of slippage to July, according to the circulated note. Another management comment referenced in the July 28, 2026 update is that QRSAM is expected to receive CCS approval by September 2026. The first off-production model is expected within 18 months of signing, which anchors the delivery timeline investors are mapping. Potential FY27 awards mentioned in the same chatter include Shatrughat and Samaghat, HAMMER, Shakti Phase-IV, and at least one of NGC or P-75I. The main investor question is less about the existence of a pipeline and more about timing, approvals, and execution pacing.

Business mix: defence heavy today, diversification targets ahead

Defence contributes approximately 90% of BEL revenue, while non-defence contributes around 10%, as cited in the discussion. Management has a stated long-term target of a 15-20% non-defence mix. The company is described as designing, manufacturing, and supplying electronic equipment and systems for defence and civilian markets in India. Social posts also list BEL’s capabilities across electronic warfare and avionics, communication, radar and fire control, weapon systems, C4I, and other defence electronics domains. The diversification debate is practical because it links to customer concentration and the dependence on government contracts. Exports currently account for 4-5% of revenue, with an FY27 export target of ₹930 crore and a longer-term aim to exceed 10%. Investors see exports as a potential stabiliser, but the current base is small compared with domestic defence revenue. The discussion generally accepts BEL’s market position and entry barriers, while treating diversification as a longer-horizon lever rather than a near-term driver.

Valuation and estimates being cited online

Valuation is a key point of disagreement in the social thread because multiple multiples are being quoted. One snapshot cited a consolidated P/E of 45.60 based on the October 1, 2026 close, and a TTM PEG ratio of 3.89 as of June 2026. Another snapshot listed Stock P/E around 46.2, along with ROCE 36.4% and ROE 27.4%. The same discussion also noted an industry P/E ratio of 57.19 in one place, and separately cited aerospace and defence industry average P/E at 63.3x in another comparison. Supporters point out that a P/E around 45.1x is below the aerospace and defence industry average cited in the thread. Skeptics argue that a PEG significantly above 1 suggests the stock is priced at a premium relative to expected growth. ICICI Direct’s target is explicitly based on 45 times FY28E EPS, with FY28E EPS cited at ₹11.7 in the broker table. The broker’s FY27E and FY28E financial estimates shared include revenue of ₹32,304 crore and ₹38,070 crore, and PAT of ₹7,045 crore and ₹8,546 crore, respectively.

Price action and technical indicators mentioned in posts

Some posts blended fundamentals with technical indicators to justify a “buy the dip” versus “wait” stance. A data snapshot cited MACD level (12,26) at 0.05 as bullish and Momentum (10) at 0.25 as bullish. The same table showed RSI (14) at 54.93 as neutral and CCI (20) at -21.75 as neutral. ADI (14) was shown at 59.47 as bullish, while the Ultimate Oscillator (7,14,28) at 54.28 was listed as neutral. Separately, a market-consensus line in the feed showed BUY at 93.33% based on “various publicly available news, publications, brokerage expectation and market data.” Another reference cited 33 analysts with an average rating of “Strong Buy” and a 12-month price target of ₹490.94, implying 33.75% upside from the latest price in that dataset. These technical and consensus signals are often used as supporting context, not as standalone proof. The key is that the stock’s proximity to its 52-week low has amplified attention to short-term signals.

Key risks investors are highlighting before buying BEL

The most repeated risk is BEL’s dependence on government contracts, which directly ties order timing to approvals and procurement schedules. Working-capital intensity is another frequent concern, with management guiding FY27 receivable days at 140-150 days and other snapshots citing high debtor days. Availability of key raw materials and components is also called out as a risk, especially when material costs affect margins. Social commentary described a phase of stable growth with margin pressure, citing Q1 FY27 margin contraction to about 25.83% due to escalating material costs. Another theme is that strong revenue growth does not always translate into stable operating leverage when input costs rise. Some summaries also describe the latest results as “mixed,” with strong revenue and profit but declining operating margins and slowing growth raising concerns. That framing is why some chatter mentions a shift from “Buy” to “Hold” in certain takes, even while ICICI Direct retained BUY. For investors, the practical checklist emerging from the discussion is backlog conversion, QRSAM timing, margin delivery versus guidance, and cash collection discipline.